Clinical Trial Update: PXD101 in Treating Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating belinostat (PXD101) in adults with acute myeloid leukemia, with results posted after completion in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Belinostat (Beleodaq) (belinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 2 | Status: COMPLETED | Results posted: 2014-10-13